LivaNova PLC
Veridion Score
Composite trend over time
Why is LIVN moving today?
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for LIVN.
LIVN insider activity
LivaNova PLC
No multi-insider buying cluster in the last 90 days
Net selling: -$3.1M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-17 | 2026-06-15 | Bianchi Francesco | Insider | sell | $80.19 | 1,200 | 9,584 | $96K | SEC Form 4 |
| 2026-06-17 | 2026-06-15 | Bianchi Francesco | Insider | sell | $79.70 | 486 | 10,784 | $39K | SEC Form 4 |
| 2026-06-17 | 2026-06-15 | PODLOGAR SUSAN M | Insider | sell | $79.70 | 486 | 5,642 | $39K | SEC Form 4 |
| 2026-06-17 | 2026-06-15 | Barry James Christopher | Insider | sell | $79.70 | 486 | 7,918 | $39K | SEC Form 4 |
| 2026-06-17 | 2026-06-15 | Tezel Ahmet | Insider | sell | $79.70 | 1,032 | 6,090 | $82K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 22 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moLIVN contract awards, year to date.
Public federal awards linked to this ticker.
LIVN lobbying filings, year to date.
Registered lobbying filings matched to LivaNova PLC.